Sterile lyophilized NAD+ powder vial for intravenous/subcutaneous wellness use (dietary supplement)
NAD+ (nicotinamide adenine dinucleotide) 500 mg lyophilized vial for IV and subcutaneous aesthetic and wellness therapy
Certifications
Described by the supplier as manufactured in accordance with European regulatory standards, adhering to high EMA and FDA regulatory expectations for sterile products, with sterile and aseptic vial filling processes carried out under GMP (Good Manufacturing Practice) standards.
Sterilisation is described as using ultrafiltration to ensure sterility and product safety.
Purity and quality control are documented via comprehensive COA testing that includes checks for sterility, micro Organisms, toxicity, heavy metals and compound purity, with a minimum purity specification of greater than 98% NAD+.
Described by the supplier as manufactured in accordance with European regulatory standards, adhering to high EMA and FDA regulatory expectations for sterile products, with sterile and aseptic vial filling processes carried out under GMP (Good Manufacturing Practice) standards.
Sterilisation is described as using ultrafiltration to ensure sterility and product safety.
Purity and quality control are documented via comprehensive COA testing that includes checks for sterility, micro Organisms, toxicity, heavy metals and compound purity, with a minimum purity specification of greater than 98% NAD+.
Regulatory status is explicitly stated as a dietary supplement classified under CAS number 53 84 9 and HS code 2934999090 in the ECICS system of the European Union, rather than as a licensed medicinal product.
Description
NAD+ Sterile Lyophilized Powder Vial 500 mg is a wholesale intravenous and subcutaneous NAD+ product supplied by Vitamin Injections London for use by trained professional practitioners. The product consists of sterile, lyophilized (freeze-dried) nicotinamide adenine dinucleotide (NAD+) powder in single-use vials, with each vial containing 500 mg of NAD+. It is positioned as a premium wellness supplement for clinic-based IV and subcutaneous protocols, marketed to support cellular energy metabolism, DNA repair, cell growth and survival. The supplier notes that NAD+ levels naturally decline with age and that replenishing NAD+ may help counter age-related cellular changes. The product is categorised as a dietary supplement under EU ECICS classification rather than as a licensed medicinal product and is accompanied by detailed information about manufacturing standards, reconstitution instructions and IV administration guidance for professional use.
Bnefits
Provides high-purity (>98%) NAD+ (nicotinamide adenine dinucleotide) in a sterile lyophilized 500 mg vial for intravenous and subcutaneous use in professional wellness and aesthetic protocols.
Marketed to support cellular energy metabolism, DNA repair, cell growth and survival, addressing age-related declines in NAD+ levels that are associated with ageing symptoms and various health conditions.
Supplied as a flexible 500 mg vial that can be reconstituted and split into several IV or subcutaneous treatments, allowing clinics to tailor dosing and increase cost-effectiveness per vial.
Manufactured in accordance with European regulatory standards with sterile and aseptic vial filling under GMP conditions and ultrafiltration sterilisation to ensure product quality.
Supported by comprehensive certificate-of-analysis testing, including sterility, micro-organisms, toxicity, heavy metals and compound purity, with a guaranteed minimum purity of greater than 98% NAD+.
Offers a shelf life of at least two years from the batch COA date when stored correctly, enabling medium-term stockholding for clinics.
Storage guidance (cool, dark environment around 5 °C with freezing permissible) aligns with standard clinical refrigeration practices.
Detailed reconstitution and IV administration guidance is provided for professional users, including standard reconstitution volume (5 ml sterile water or saline) and typical drip time (3–4 hours) for a 500 mg NAD+ infusion.
Regulatory status is explicitly stated as a dietary supplement classified under CAS number 53 84 9 and HS code 2934999090 in the ECICS system of the European Union, rather than as a licensed medicinal product.
No MHRA marketing authorisation (PL number), EMA European Public Assessment Report (EPAR), CE/UKCA medical device certification or official medicinal SmPC has been identified for this specific NAD+ 500 mg lyophilized vial product.
No MHRA marketing authorisation (PL number), EMA European Public Assessment Report (EPAR), CE/UKCA medical device certification or official medicinal SmPC has been identified for this specific NAD+ 500 mg lyophilized vial product.
NAD+ (nicotinamide adenine dinucleotide) 500 mg lyophilized vial for IV and subcutaneous aesthetic and wellness therapy
Indications
Intended for professional intravenous and subcutaneous administration as part of wellness and anti-ageing NAD+ protocols in aesthetic and IV therapy clinics.
Marketed for practitioners seeking to support clients’ cellular energy, DNA repair processes and overall vitality via NAD+ supplementation.
Promoted in the context of anti-ageing, health and wellness treatments rather than as a licensed medicinal therapy for specific diseases.
Explicitly indicated by the supplier for use by trained professional practitioners only; not intended for self-administration by laypersons.
Regulatory status described as a dietary supplement (CAS 53-84-9, HS code 2934999090) under ECICS classification, not as an MHRA-authorised medicinal product.
Composition
Active substance: NAD+ (nicotinamide adenine dinucleotide), a vitamin B3-derived coenzyme essential for cellular energy metabolism, DNA repair, cell growth and survival.
Quantity per vial: 500 mg NAD+ lyophilized powder.
Minimum purity specification: greater than 98% NAD+, verified via certificate-of-analysis testing.
Regulatory identifiers: categorised as a dietary supplement under CAS number 53-84-9 and HS code 2934999090 according to ECICS of the European Union.
No additional excipients, stabilisers or buffer components are publicly disclosed for these vials; a full qualitative and quantitative excipient list is not publicly listed.
Formulation
Dosage form: sterile lyophilized (freeze-dried) NAD+ powder in glass vials for reconstitution.
Strength: 500 mg NAD+ per vial (with a separate 1000 mg vial strength also available in the same product range).
Vial size: 5 ml vial associated with the 500 mg presentation, as stated in the product overview (500 mg per vial | 1000 mg per vial; vial size 5 ml | 10 ml).
Intended routes of administration: intravenous infusion and subcutaneous injection after reconstitution, for use by trained healthcare or aesthetic practitioners.
Sterilisation: ultrafiltration-based process for sterile and aseptic vial filling as described by the supplier.
Manufacturing: produced under GMP standards, with manufacturing described as adhering to European regulatory standards and to high EMA and FDA regulatory expectations for sterile products.
Packaging
Supplied as individual sterile glass vials containing 500 mg of lyophilized NAD+ powder, sealed with a rubber stopper and crimped cap (as shown in the NAD+ wholesale product imagery).
Vial size for the 500 mg strength is listed as 5 ml, suitable for reconstitution with 5 ml of sterile water or 0.9% saline.
Wholesale minimum order quantity is 10 vials per order.
The product is part of the NAD+ Wholesale range offered by Vitamin Injections London, grouped with 500 mg and 1000 mg vial options.
Information about secondary packaging such as outer cartons, pack inserts or labelling artwork is not publicly detailed; only general vial-based product images and high-level packaging information are provided.
Usage
Professional use only: the product is explicitly stated to be for trained/professional practitioners only and is not intended for layperson self-administration.
Reconstitution preparation steps include gathering a lyophilized NAD+ vial (500 mg), sterile water or 0.9% saline, syringe, needle, alcohol swabs and optionally a 500 ml 0.9% sodium chloride IV bag, while maintaining a sterile work area and wearing gloves.
Before reconstitution, the vial should be checked for damage and the rubber stopper disinfected with an alcohol swab.
Standard reconstitution instructions direct users to inject 5 ml of sterile water or saline into the vial and gently swirl to dissolve the lyophilized powder, avoiding excessive agitation, then confirm that the solution is clear and free of particulates before use.
For IV administration, the reconstituted solution is transferred to a 500 ml 0.9% saline IV bag.
IV administration guidance advises starting the IV drip slowly and adjusting the flow to match the client’s tolerance during the first 20 minutes, monitoring for symptoms such as dizziness, increased heart rate or abdominal discomfort.
Typical infusion duration stated is 3–4 hours for a 500 mg NAD+ drip.
The supplier includes an advisory to consult a doctor before proceeding with NAD+ IV treatment if the client has heart conditions, is pregnant, has a pacemaker or has cancer.
Subcutaneous use guidance in the product information is primarily described for the 1000 mg vial (e.g. reconstituting with 1 ml sterile water/saline and drawing 100 mg for subcutaneous injection), but it indicates that the lyophilized NAD+ vials may also be used for SC injections under appropriate professional protocols.
No fixed dosing regimen, treatment schedule or course length is mandated; practitioners are expected to determine dosing and frequency based on their own clinical judgement and protocols.
Contraindications
Formal medicinal contraindications equivalent to a licensed product SmPC (e.g. specific disease-related contraindications) are not publicly listed for this NAD+ 500 mg lyophilized vial.
The supplier includes an advisory that individuals with heart conditions, pregnancy, pacemakers or cancer should consult a doctor before undergoing NAD+ IV therapy using this product.
Because the product is positioned as a dietary supplement for wellness use rather than a licensed medicine, no official contraindication section from a regulatory SmPC is available.
Adverse Effects
Not publicly listed (no formal adverse reaction profile, frequency table or safety section equivalent to a medicinal product SmPC is provided for this NAD+ 500 mg lyophilized vial).
Storage Conditions
Storage instructions specify keeping the lyophilized NAD+ vials in dark, cool conditions, with an optimal storage temperature of approximately 5 °C.
Freezing of the product is described as permissible by the supplier.
Shelf life is stated as at least two years from the batch certificate-of-analysis (COA) date, verified by third-party testing.
No additional public information is provided on in-use stability after reconstitution or specific light protection requirements beyond the general recommendation to store in dark, cool conditions.
Duration
Publicly available information specifies that a typical IV infusion time for a 500 mg NAD+ drip made from this product is approximately 3\u20134 hours; no standardised course length (number of sessions, treatment cycles or long-term duration) is defined in the supplier information and treatment planning is left to practitioner discretion.
